The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples